Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|9|4|371-384
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.4, 2009-01, pp. : 371-384
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Medical Lipid-Regulating Therapy: Current Evidence, Ongoing Trials and Future Developments
By Evans M.
Drugs, Vol. 64, Iss. 11, 2004-01 ,pp. :
Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets, Vol. 15, Iss. 2, 2014-02 ,pp. :
Management of Osteoporosis: Seeing the Future
Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 4, 2004-10 ,pp. :
The future of pharmacogenetics for osteoporosis
By Marini Francesca Brandi Maria Luisa
Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. :